| For: | Hong E, Chen XE, Mao J, Zhou JJ, Chen L, Xu JY, Tao W. Sequential occurrence of T790M mutation and small cell lung cancer transformation in EGFR-positive lung adenocarcinoma: A case report. World J Clin Cases 2022; 10(9): 2836-2843 [PMID: 35434119 DOI: 10.12998/wjcc.v10.i9.2836] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v10/i9/2836.htm |
| Number | Citing Articles |
| 1 |
Shuai Wang, Yongsen Wang, Xuan Wu, Li Yang, Xiaoju Zhang. Patients outcomes in lung adenocarcinoma transforming to small-cell lung cancer after tyrosine kinase inhibitor therapy. World Journal of Surgical Oncology 2025; 23(1) doi: 10.1186/s12957-025-03687-4
|
| 2 |
Qiqi Gao, Lixin Zhang, Yulong Zheng. Clinicopathological and molecular features of non-small cell lung cancer that transform to small-cell lung cancer: Case reports and literature review. Polish Journal of Pathology 2025; 76(2) doi: 10.5114/pjp.2025.153971
|
| 3 |
|
| 4 |
Jie-Mei Jiang, Zi-Wei Cheng, Li Zhang, Ting-Fei Tan, Teng Zhang, Han-Bing Shi, Kai-Feng Hou, Quan Xia. Proteomic insights into the molecular mechanism of anlotinib inhibition in TP53-mutated non-small cell lung cancer. Journal of Proteomics 2025; 316 doi: 10.1016/j.jprot.2025.105433
|